Ottawa, October 23, 2020—Innovative Medicines Canada (IMC) issued the following statement in response to the potential disclosure of proprietary or confidential business information regarding the procurement of COVID-19 medicines and […]
STATEMENT Ottawa, September 25, 2020 – The following statement can be attributed to Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance, Innovative Medicines Canada in response to the Trump […]
STATEMENT Ottawa, September 23, 2020 – Pamela Fralick, President of Innovative Medicines Canada, issued the following statement in response to today’s Speech from the Throne: “COVID-19 has shown just how […]
The PMPRB revised Guidelines will result in patients losing access […]
The Health Research Foundation of IMC is pleased to […]
We have just received the Federal Court’s decision […]
IMC released the following statement […]
Ottawa, June 1, 2020 – Innovative Medicines Canada released the following statement today in response to the announcement by Health Canada that implementation of the amendments to the Patented Medicines […]
IMC today announced the creation of a Research Chair in pandemic preparedness […]
Members of Innovative Medicines Canada continue to support front line workers […]
